4//SEC Filing
Hicks Derek 4
Accession 0001209191-22-001651
CIK 0001652130other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:15 PM ET
Size
7.4 KB
Accession
0001209191-22-001651
Insider Transaction Report
Form 4
Hicks Derek
EVP, Chief Business Officer
Transactions
- Award
Common Stock
2022-01-03+19,118→ 19,118 total - Award
Stock option (right to buy)
2022-01-03+25,000→ 25,000 totalExercise: $118.99Exp: 2032-01-02→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on January 3, 2022 with respect to 25,000 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 25% vesting on December 20, 2022 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001901282
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:15 PM ET
- Size
- 7.4 KB